Natixis Investment Managers International’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $5.85M | Sell |
11,250
-581
| -5% | -$319K | 0.45% | 35 |
|
|
2024
Q3 | $7.32M | Sell |
11,831
-91
| -0.8% | -$53.9K | 0.52% | 33 |
|
|
2024
Q2 | $6.59M | Sell |
11,922
-472
| -4% | -$270K | 0.49% | 32 |
|
|
2024
Q1 | $7.2M | Sell |
12,394
-555
| -4% | -$311K | 0.49% | 30 |
|
|
2023
Q4 | $6.87M | Sell |
12,949
-58
| -0.4% | -$28.1K | 0.49% | 35 |
|
|
2023
Q3 | $6.58M | Sell |
13,007
-626
| -5% | -$334K | 0.51% | 36 |
|
|
2023
Q2 | $7.11M | Buy |
13,633
+364
| +3% | +$196K | 0.53% | 34 |
|
|
2023
Q1 | $7.65M | Sell |
13,269
-1,420
| -10% | -$800K | 0.58% | 33 |
|
|
2022
Q4 | $8.09M | Buy |
14,689
+337
| +2% | +$179K | 0.6% | 32 |
|
|
2022
Q3 | $7.28M | Sell |
14,352
-657,664
| -98% | -$368M | 0.58% | 33 |
|
|
2022
Q2 | $365M | Sell |
672,016
-175
| -0% | -$96.3K | 7.43% | 1 |
|
|
2022
Q1 | $397M | Buy |
672,191
+657,239
| +4,396% | +$378M | 6.94% | 1 |
|
|
2021
Q4 | $9.98M | Sell |
14,952
-881
| -6% | -$550K | 0.55% | 31 |
|
|
2021
Q3 | $9.04M | Sell |
15,833
-597
| -4% | -$328K | 0.52% | 31 |
|
|
2021
Q2 | $8.29M | Sell |
16,430
-138
| -0.8% | -$65.1K | 0.5% | 29 |
|
|
2021
Q1 | $7.56M | Sell |
16,568
-45,664
| -73% | -$21.8M | 0.52% | 33 |
|
|
2020
Q4 | $29M | Buy |
+62,232
| New | +$29.2M | 2.02% | 18 |
|
|
2018
Q4 | – | Sell |
-325,496
| Closed | -$79.4M | – | 508 |
|
|
2018
Q3 | $79.4M | Buy |
325,496
+7,988
| +3% | +$1.84M | 3.71% | 3 |
|
|
2018
Q2 | $65.8M | Buy |
317,508
+61,170
| +24% | +$13M | 3.62% | 3 |
|
|
2018
Q1 | $52.9M | Buy |
256,338
+95,690
| +60% | +$20.1M | 3.78% | 2 |
|
|
2017
Q4 | $30.5M | Buy |
160,648
+11,540
| +8% | +$2.21M | 3.4% | 6 |
|
|
2017
Q3 | $28.2M | Sell |
149,108
-1,034
| -0.7% | -$187K | 2.44% | 7 |
|
|
2017
Q2 | $26.2M | Sell |
150,142
-11,599
| -7% | -$1.95M | 2.29% | 8 |
|
|
2017
Q1 | $24.8M | Buy |
161,741
+6,884
| +4% | +$1.05M | 2.19% | 7 |
|
|
2016
Q4 | $21.9M | Buy |
154,857
+13,005
| +9% | +$1.92M | 2.06% | 6 |
|
|
2016
Q3 | $22.6M | Buy |
141,852
+15,446
| +12% | +$2.38M | 2.31% | 6 |
|
|
2016
Q2 | $18.7M | Buy |
126,406
+3,816
| +3% | +$563K | 2.04% | 6 |
|
|
2016
Q1 | $17.4M | Buy |
122,590
+73
| +0.1% | +$9.78K | 2.06% | 7 |
|
|
2015
Q4 | $17.4M | Buy |
122,517
+533
| +0.4% | +$71.1K | 2.25% | 5 |
|
|
2015
Q3 | $14.9M | Buy |
121,984
+524
| +0.4% | +$68.3K | 2.01% | 6 |
|
|
2015
Q2 | $15.8M | Buy |
121,460
+1,734
| +1% | +$226K | 1.94% | 5 |
|
|
2015
Q1 | $16.1M | Sell |
119,726
-6,267
| -5% | -$808K | 2.05% | 6 |
|
|
2014
Q4 | $15.8M | Buy |
125,993
+49,377
| +64% | +$6M | 2.08% | 5 |
|
|
2014
Q3 | $9.32M | Buy |
76,616
+31,553
| +70% | +$3.84M | 1.35% | 16 |
|
|
2014
Q2 | $5.32M | Sell |
45,063
-5,715
| -11% | -$673K | 0.7% | 32 |
|
|
2014
Q1 | $6.11M | Buy |
50,778
+4,956
| +11% | +$589K | 0.86% | 28 |
|
|
2013
Q4 | $5.1M | Sell |
45,822
-3,304
| -7% | -$329K | 0.93% | 23 |
|
|
2013
Q3 | $4.53M | Sell |
49,126
-5,158
| -10% | -$466K | 1.03% | 22 |
|
|
2013
Q2 | $4.59M | Buy |
+54,284
| New | +$4.52M | 1.07% | 19 |
|
Other funds holding TMO
Natixis Investment Managers International's TMO Position: Q4 2024 in Review
Natixis Investment Managers International reduced its Thermo Fisher Scientific (TMO) stake by 4.9% in Q4 2024, selling an estimated $319K and leaving 11,250 shares worth $5.85M. The position accounts for 0.45% of the portfolio, ranked #35.
Natixis Investment Managers International first reported a position in TMO in Q2 2013 and has held it in 39 quarters since. The position peaked at $397M in Q1 2022. 2,617 funds tracked by Wall St. Rank hold TMO as of Q4 2024.
- Natixis Investment Managers International held 11,250 shares of Thermo Fisher Scientific worth $5.85M as of Q4 2024.
- Natixis Investment Managers International sold 581 Thermo Fisher Scientific shares in Q4 2024, an estimated $319K.
- Thermo Fisher Scientific made up 0.45% of Natixis Investment Managers International's portfolio in Q4 2024, its #35 holding.
- Natixis Investment Managers International first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 39 quarters since.
- Natixis Investment Managers International's Thermo Fisher Scientific position peaked at $397M in Q1 2022.
- 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.
Based on Natixis Investment Managers International's 13F filing for Q4 2024, filed 13 Feb 2025.